CME Session
Hybrid Session
David McDermott, MD
Beth Israel Deaconess Medical Center
Disclosure: Disclosure(s): Contract Research: Alkermes, Inc (Ongoing); BMS (Ongoing); Checkmate Pharmaceuticals (Ongoing); CRISPR Therapeutics (Ongoing); Exelixis (Ongoing); Merck (Ongoing); Pfizer (Ongoing); Roche/Genentech (Ongoing); X4 Pharma (Ongoing)
Non-CE Consulting: Alkermes, Inc (Ongoing); Aveo (Ongoing); BMS (Ongoing); Calithera (Ongoing); Eisai (Ongoing); Eli Lilly (Ongoing); EMD Serono (Ongoing); Iovance (Ongoing); Johnson & Johnson (Ongoing); Merck (Ongoing); Pfizer (Ongoing); Synthekind, Inc (Ongoing); werewolf therapeutics (Ongoing)